These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 31205627)
21. What regulates hepcidin in poly-transfused β-Thalassemia Major: erythroid drive or store drive? Chauhan R; Sharma S; Chandra J Indian J Pathol Microbiol; 2014; 57(1):39-42. PubMed ID: 24739829 [TBL] [Abstract][Full Text] [Related]
22. The Effect of Long-Term Iron Chelator Therapy on Serum Levels of Hepcidin and Ferritin in Patients with Thalassemia Major and Intermediate. Eshagh Hossaini SK; Haeri MR; Seif F Indian J Hematol Blood Transfus; 2022 Oct; 38(4):750-753. PubMed ID: 36258735 [TBL] [Abstract][Full Text] [Related]
23. Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis C virus infection. Hendy OM; Allam M; Allam A; Attia MH; El Taher S; Eldin MM; Ali A Egypt J Immunol; 2010; 17(2):33-44. PubMed ID: 23082485 [TBL] [Abstract][Full Text] [Related]
24. HFE mutation H63D predicts risk of iron over load in thalassemia intermedia irrespective of blood transfusions. Sharma V; Panigrahi I; Dutta P; Tyagi S; Choudhry VP; Saxena R Indian J Pathol Microbiol; 2007 Jan; 50(1):82-5. PubMed ID: 17474269 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of Iron Overload Between Age Groups Using Magnetic Resonance Imaging and Its Correlation with Iron Profile in Transfusion-dependent Thalassemia. Wahidiyat PA; Iskandar SD; Sekarsari D Acta Med Indones; 2018 Jul; 50(3):230-236. PubMed ID: 30333273 [TBL] [Abstract][Full Text] [Related]
26. [HFE gene mutations in Tunisian major beta-Thalassemia and iron overload]. Mellouli F; El Borgi W; Kaabi H; Ben Hassen E; Sassi R; Hmida H; Cherif G; Maamar M; Zouari B; Boukef K; Bejaoui M; Hmida S Transfus Clin Biol; 2006 Dec; 13(6):353-7. PubMed ID: 17303462 [TBL] [Abstract][Full Text] [Related]
27. Correlation between Heart, Liver and Pancreas Hemosiderosis Measured by MRI T2* among Thalassemia Major Patients from Iran. Azarkeivan A; Hashemieh M; Shirkavand A; Sheibani K Arch Iran Med; 2016 Feb; 19(2):96-100. PubMed ID: 26838079 [TBL] [Abstract][Full Text] [Related]
28. Relationship Between Serum Hepcidin and Ferritin Levels in Patients With Thalassemia Major and Intermedia in Southern Iran. Haghpanah S; Esmaeilzadeh M; Honar N; Hassani F; Dehbozorgian J; Rezaei N; Abdollahi M; Bardestani M; Safaei S; Karimi M Iran Red Crescent Med J; 2015 Jul; 17(7):e28343. PubMed ID: 26421179 [TBL] [Abstract][Full Text] [Related]
29. The Effects of AlFadhli S; Salem M; Shome DK; Mahdi N; Nizam R Indian J Hematol Blood Transfus; 2017 Dec; 33(4):545-551. PubMed ID: 29075067 [TBL] [Abstract][Full Text] [Related]
30. Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre. Ryan E; Ryan JD; Russell J; Coughlan B; Tjalsma H; Swinkels DW; Stewart S; Crowe JP Acta Haematol; 2015; 133(2):155-61. PubMed ID: 25277871 [TBL] [Abstract][Full Text] [Related]
31. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Bridle KR; Frazer DM; Wilkins SJ; Dixon JL; Purdie DM; Crawford DH; Subramaniam VN; Powell LW; Anderson GJ; Ramm GA Lancet; 2003 Feb; 361(9358):669-73. PubMed ID: 12606179 [TBL] [Abstract][Full Text] [Related]
32. Imbalance of erythropoiesis and iron metabolism in patients with thalassemia. Huang Y; Lei Y; Liu R; Liu J; Yang G; Xiang Z; Liang Y; Lai Y Int J Med Sci; 2019; 16(2):302-310. PubMed ID: 30745811 [No Abstract] [Full Text] [Related]
33. Assessment of Heart and Liver Iron Overload in Thalassemia Major Patients Using T2* Magnetic Resonance Imaging. Farhangi H; Badiei Z; Moghaddam HM; Keramati MR Indian J Hematol Blood Transfus; 2017 Jun; 33(2):228-234. PubMed ID: 28596656 [TBL] [Abstract][Full Text] [Related]
34. T2-star (T2*) magnetic resonance imaging for assessment of kidney iron overload in thalassemic patients. Hashemieh M; Azarkeivan A; Akhlaghpoor S; Shirkavand A; Sheibani K Arch Iran Med; 2012 Feb; 15(2):91-4. PubMed ID: 22292579 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of the Association of Transferrin Receptor Type 2 Gene Mutation (Y250X) with Iron Overload in Major β- Thalassemia. Abdulmalek Jaafar J; Al-Rashedi NAM Arch Razi Inst; 2021 Nov; 76(5):1551-1554. PubMed ID: 35355750 [TBL] [Abstract][Full Text] [Related]
36. Aortic elasticity changes in thalassemia due to heart and liver iron deposition. Noori NM; Teimouri A Caspian J Intern Med; 2023; 14(3):460-469. PubMed ID: 37520866 [TBL] [Abstract][Full Text] [Related]
37. Frequency of HFE gene mutations in Iranian beta-thalassaemia minor patients. Jazayeri M; Bakayev V; Adibi P; Haghighi Rad F; Zakeri H; Kalantar E; Zali MR Eur J Haematol; 2003 Dec; 71(6):408-11. PubMed ID: 14703689 [TBL] [Abstract][Full Text] [Related]
38. Association of HFE mutations (C282Y and H63D) with iron overload in blood donors from Mexico City. Baptista-González HA; Rosenfeld-Mann F; Trueba-Gómez R; Bermejo-Martínez L; Méndez-Sánchez N Ann Hepatol; 2007; 6(1):55-60. PubMed ID: 17297430 [TBL] [Abstract][Full Text] [Related]
39. Serum Ferritin Levels Correlation With Heart and Liver MRI and LIC in Patients With Transfusion-Dependent Thalassemia. Majd Z; Haghpanah S; Ajami GH; Matin S; Namazi H; Bardestani M; Karimi M Iran Red Crescent Med J; 2015 Apr; 17(4):e24959. PubMed ID: 26023341 [TBL] [Abstract][Full Text] [Related]
40. Myocardial and liver iron overload, assessed using T2* magnetic resonance imaging with an excel spreadsheet for post processing in Tunisian thalassemia major patients. Ouederni M; Ben Khaled M; Mellouli F; Ben Fraj E; Dhouib N; Yakoub IB; Abbes S; Mnif N; Bejaoui M Ann Hematol; 2017 Jan; 96(1):133-139. PubMed ID: 27730342 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]